Skip to main content
All lobbying filings

MEDTRONIC, INC.

Lobbying for MEDTRONIC INC

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $940,000.00 expenses · posted Apr 20, 2026

Official filing document

 Bills named in this filing 9
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 1399
    Health Tech Investment Act
  • HR 6197
    Health Tech Investment Act
  • S 3658
    SHIFT Act
  • HR 1539
    Medical Device Electronic Labeling Act
  • S 1553
    PREVAIL Act
  • S 1546
    Patent Eligibility Restoration Act of 2025
  • S 708
    RESTORE Patent Rights Act of 2025
 Lobbying activity 13
Medicare/Medicaid

Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to DME competitive bidding Issues related to non-opioid pain therapies Issues related to transcatheter heart valves

Taxation/Internal Revenue Code

Issues related to the taxation of multinational corporations corporations

Trade (domestic/foreign)

Issues related to global supply chains including rare earth and critical minerals including S.3658 the Securing Essential and Critical U.S. Resources and Elements Minerals Act of 2026 Issues related to tariffs

Health Issues

Issues related to medical device electronic labeling, including H.R. 1539 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to diabetes Issues related to epilepsy Issues related to overactive bladder and urinary incontinence

Telecommunications

Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015

Labor Issues/Antitrust/Workplace

Issues related to anti-trust and competition

Copyright/Patent/Trademark

Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025

Environment/Superfund

Monitoring Environmental, Social and Governance (ESG) issues Issues related to the sterilization of medical devices Issues related to the use of polyfluoroalkyl substances

Consumer Issues/Safety/Products

Issues related to data privacy and data security Issues related to artificial intelligence enabled medical devices and emerging technologies Issues related to right to repair

Veterans

Issues related to hypertension Issues related to procurement of healthcare technologies

Defense

Issues related to the National Defense Authorization Act for Fiscal Year 2027 including servicing and repair of medical devices

Budget/Appropriations

Issues related to hypertension, including FY27 MilCon/Veterans Appropriations Issues related to overactive bladder and urinary incontinence, including FY27 Labor/HHS Appropriations

Civil Rights/Civil Liberties

Issues related to third party litigating funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem